Alembic Pharmaceuticals Receives US FDA Approval for Olopatadine Eye Drops
Alembic Pharmaceuticals receives final US FDA approval for its olopatadine hydrochloride ophthalmic solution USP, 0.7 per cent, an OTC treatment for itchy eyes.
Itchy Eyes | 05/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy